Analysis of influencing factors of low molecular weight heparin calcium and pancreatic endocrine function in patients with acute pancreatitis

Minerva Gastroenterol (Torino). 2022 Sep;68(3):349-352. doi: 10.23736/S2724-5985.21.02966-1. Epub 2022 Feb 3.

Authors

Weihua Deng¹, Mingyang Wang¹, Dezhong Li¹, Qibing Wang¹, Liu Liu², Changsong Cai³

Affiliations

¹ Department of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
² Department of Pediatrics, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
³ Department of General Surgery, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China - 652282022@qq.com.

PMID: 35112819
DOI: 10.23736/S2724-5985.21.02966-1

No abstract available

MeSH terms

Acute Disease
Anticoagulants / therapeutic use
Heparin
Heparin, Low-Molecular-Weight* / therapeutic use
Humans
Pancreatitis* / drug therapy

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Heparin